The CD95(APO-1/Fas)/CD95L system

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 131-137

  Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95(APO 1 Fas); Signaling in apoptosis

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; AUTOIMMUNE DISEASE; CONFERENCE PAPER; HUMAN; LIVER FUNCTION; LYMPHADENOPATHY; MUTATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; HOMEOSTASIS; HUMANS; LIVER; MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION;

EID: 0032436412     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00297-5     Document Type: Conference Paper

References (43)

1. Adachi, M., Suematsu, S., Kondo, T., Ogasawara, J., Tanaka, T., Yoshida, N., Nagata, S., 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11, 294-300.
2. Anel, A., Simon, A.K., Auphan, N., Buferne, M., Boyer, C., Golstein, P., Schmitt-Verhulst, A.M., 1995. Two signalling pathways can lead to Fas ligand expression in CD8 + cytotoxic T lymphocyte clones. Eur. J. Immunol. 25, 3381-3387.
3. Banner, D.W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.J., Broger, C., Loetscher, H., Lesslauer, W., 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431-445.
4. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., Wallach, D., 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
5. Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J., Mountz, J.D., 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762.
6. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., Dixit, V.M., 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
7. Cifone, M.G., De Maria, R., Roncaioli, P., Rippo, M.R., Azuma, M., Lanier, L.L., Santoni, A., Testi, R., 1994. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180, 1547-1552.
8. Copeland, K.F., Haaksma, A.G., Goudsmit, J., Krammer, P.H., Heeney, J.L., 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses 10, 1259-1268.
9. Cuppen, E., Nagata, S., Wieringa, B., Hendriks, W., 1997. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J. Biol. Chem. 48, 30215-30220.
10. Dhein, J., Daniel, P.T., Trauth, B.C., Oehm, A., Moller, P., Krammer, P.H., 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149, 3166-3173.
11. Dhein, J., Walczak, H., Baumler, C., Debatin, K.M., Krammer, P.H., 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
12. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., Puck, J.M., 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
13. French, L.E., Hahne, M., Viard, I., Radlgruber, G., Zanone, R., Becker, K., Muller, C., Tschopp, J., 1996. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell. Biol. 133, 335-343.
14. Galle, P.R., Hofmann, W.J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P.H., Runkel, L., 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
15. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., Nagata, S., 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
16. Itoh, N., Tsujimoto, Y., Nagata, S., 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621-627.
17. Klas, C., Debatin, K.-M., Jonker, R.R., Krammer, P.H., 1993. Activation interferes with the apoptotic pathway in mature human T cells. Int. Immunol. 5, 625-630.
18. Kolesnick, R.N., Haimovitz Friedman, A., Fuks, Z., 1994. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 72, 471-474.
19. Krammer, P.H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P.T., Knipping, E., Westendorp, M.O., Stricker, K., Bäumler, C., Hellbardt, S., Germer, M., Peter, M.E., Debatin, K.-M., 1994a. The role of APO-1 mediated apoptosis in the immune system. Immunol. Rev. 142, 175-191.
20. Krammer, P.H., Behrmann, I., Daniel, P., Dhein, J., Debatin, K.-M., 1994b. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6, 279-289.
21. Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Bruderlein, S., Henne, C., Schmidt, A., Debatin, K.M., Krammer, P.H., Moller, P., 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429.
22. Lichter, P., Walczak, H., Weitz, S., Behrmann, I., Krammer, P.H., 1992. The human APO-1 antigen maps to 10q23, a region which is syntenic with mouse chromosome 19. Genomics 14, 179-180.
23. Mariani, S.M., Matiba, B., Baumler, C., Krammer, P.H., 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25, 2303-2307.
24. Möller, P., Koretz, K., Leithäuser, F., Brüderlein, S., Henne, C., Quentmeier, A., Krammer, P.H., 1994. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer 57, 1-7.
25. Nagata, S., Golstein, P., 1995. The Fas death factor. Science 267, 1449-1456.
26. Ni, R., Tomita, Y., Matsuda, K., Ichihara, A., Ishimura, K., Ogasawara, J., Nagata, S., 1994. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell. Res. 215, 332-337.
27. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li Weber, M., Richards, S., Dhein, J., Trauth, B.C., et al., 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267, 10709-10715.
28. Rieux Laucat, F., Le Deist, F., Hivroz, C., Roberts, I.A., Debatin, K.M., Fischer, A., de Villartay, J.P., 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
29. Rothstein, T.L., Wang, J.K., Panka, D.J., Foote, L.C., Wang, Z.U., Stanger, B., Cui, H., Ju, S.T., Marshak-Rothstein, A., 1995. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
30. Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., Seed, B., 1995. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523.
31. Suda, T., Takahashi, T., Golstein, P., Nagata, S., 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
32. Suda, T., Hashimoto, H., Tanaka, M., Ochi, T., Nagata, S., 1997. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186, 2045-2050.
33. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T., Nagata, S., 1994a. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
34. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., Nagata, S., 1994b. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567-1574.
35. Tanaka, M., Suda, T., Takahashi, T., Nagata, S., 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135.
36. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A.H., Nagata, S., 1996. Fas ligand in human serum. Nat. Med. 2, 317-322.
37. Tartaglia, L.A., Ayres, T.M., Wong, G.H., Goeddel, D.V., 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853.
38. Tepper, C.G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y.A., Seldin, M.F., 1995. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8443-8447.
39. Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Moller, P., Falk, W., Debatin, K.M., Krammer, P.H., 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
40. Watanabe-Fukunaga, R., Brannan, C.I., Itoh, N., Yonehara, S., Copeland, N.G., Jenkins, N.A., Nagata, S., 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
41. Yagita, H., Hanabuchi, A., Asano, Y., Tamura, N., Nariuchi, H., Okumura, K., 1995. Fas-mediated cytotoxicity - a new immunoregulatory and pathogenic function of Th1 CD4 + T cells. Immunol. Rev. 146, 223-239.
42. Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B., Korsmeyer, S.J., 1995. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291.
43. Zheng, L., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H., Lenardo, M.J., 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348-351.